Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 February 2024.Powered by Capital Market - Live News

Net profit of Balaxi Pharmaceuticals rose 65.13% to Rs 13.59 crore in the quarter ended December 2023 as against Rs 8.23 crore during the previous quarter ended December 2022. Sales declined 29.79% to Rs 60.79 crore in the quarter ended December 2023 as against Rs 86.58 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales60.7986.58 -30 OPM %22.4717.67 - PBDT13.1110.71 22 PBT12.6310.53 20 NP13.598.23 65 Powered by Capital Market - Live News

Net profit of Balaxi Pharmaceuticals declined 6.84% to Rs 14.43 crore in the quarter ended September 2023 as against Rs 15.49 crore during the previous quarter ended September 2022. Sales declined 36.65% to Rs 54.72 crore in the quarter ended September 2023 as against Rs 86.38 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales54.7286.38 -37 OPM %19.6617.08 - PBDT10.6718.87 -43 PBT10.0118.68 -46 NP14.4315.49 -7 Powered by Capital Market - Live News

Net profit of Balaxi Pharmaceuticals declined 70.35% to Rs 1.18 crore in the quarter ended September 2023 as against Rs 3.98 crore during the previous quarter ended September 2022. Sales declined 41.44% to Rs 16.55 crore in the quarter ended September 2023 as against Rs 28.26 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales16.5528.26 -41 OPM %5.5012.49 - PBDT1.706.01 -72 PBT1.575.93 -74 NP1.183.98 -70 Powered by Capital Market - Live News

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2 November 2023.Powered by Capital Market - Live News